For all the health data sitting on computers in this country, our drug safety surveillance is remarkably primitive, relying on clinical trials (which capture a tiny percentage of those taking prescription drugs) and sporadic reports from doctors and drugmakers.
A deal being announced today could change that. The FDA will contract with WellPoint, the country’s biggest [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment